Posted by ed_uk2010 on September 30, 2010, at 14:31:49
In reply to rejected for schizophrenia?, posted by Jeroen on September 29, 2010, at 15:17:39
The European Medicines Agency (EMEA) examined the data submitted by the manufacturer. They concluded that the data was insufficient to demonstrate that Sycrest was effective for schizophrenia. So yes, it was rejected as a treatment for schizophrenia, but was accepted for manic episodes in bipolar disorder.
poster:ed_uk2010
thread:963606
URL: http://www.dr-bob.org/babble/20100926/msgs/964294.html